Lowering specific NAD+ precursors in the diet, silencing or inhibiting NAPRT in cancer cells or depleting the gut microbiota using antibiotics are all potential avenues for optimizing the activity of NAMPT inhibitors in hematological malignancies. The gene discussed is NAPRT; the disease is hematologic disorder.